Larvol Delta - Efficacy-and-safety-of-transarterial-chemoembolization-combined-with-donafenib-and-camrelizumab-for-hepatocellular-carcinoma-with-portal-vein-tumor-thrombus-a-dualcenter-retrospective-propensity-scorematched-analysis

Zepsun (donafenib) - Suzhou Zelgen

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42620307

Hezi Qing; Qi Zhang; Xingwu Xie; Zhenwu Lei

Aug 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next